پیوندهای مفید
آمار
| تعداد نشریات | 31 |
| تعداد شماره‌ها | 503 |
| تعداد مقالات | 4,885 |
| تعداد مشاهده مقاله | 7,525,231 |
| تعداد دریافت فایل اصل مقاله | 5,608,636 |
Prevalence of Ten Common Iranian β-thalassemia Mutations Among β-thalassemia Patients in Kashan Using ARMS-PCR | ||
| Journal of Genetic Resources | ||
| مقالات آماده انتشار، پذیرفته شده، انتشار آنلاین از تاریخ 31 تیر 1404 اصل مقاله (446.32 K) | ||
| نوع مقاله: Research Article | ||
| شناسه دیجیتال (DOI): 10.22080/jgr.2025.28706.1425 | ||
| نویسندگان | ||
| Zahra Rezvani* 1؛ Hossein Nikzad2؛ Arezou Heydari1 | ||
| 1Department of Cell and Molecular Biology, Faculty of Chemistry, University of Kashan, Kashan, Iran | ||
| 2Gametogenesis Research Center, Kashan University of Medical Sciences, Kashan, Iran | ||
| تاریخ دریافت: 25 اردیبهشت 1404، تاریخ بازنگری: 23 اردیبهشت 1404، تاریخ پذیرش: 13 تیر 1404 | ||
| چکیده | ||
| Thalassemia is a prevalent inherited hematological disorder that affects erythrocyte production. This chronic condition is caused by mutations in the globin gene, resulting in either a reduction or complete absence of one of the two globin chains- alpha or beta. The β-thalassemia is an inherited hematological disorder with an autosomal recessive pattern. In Iran, this disease can be caused by at least 47 different mutations in the β-globin gene, with approximately 10 common mutations accounting for over 80% of β-thalassemia cases. This study aimed to identify the spectrum of common β-thalassemia mutations among β-thalassemia patients in Kashan, located in central Iran. In present study 40 β-thalassemia patients (major and intermedia) were analyzed. DNA was extracted from whole blood samples utilizing the salting-out method. Screening for causal mutations was conducted using the amplification refractory mutation system PCR (ARMS-PCR) technique. Among the 10 common mutations, IVS II-I was the predominant mutation (30%), followed by Fr 36-37 (20%), Fr 8-9 (15%), IVS I-110 (12.5%), codon 8 (10%), IVS I-6 (7.5%), and IVS I-5 (5%). The mutations IVS I 3´end (-25 del), codon 44, and codon 39 were not detected in this study. The findings indicate that the Kashan population exhibits a diverse range of thalassemia allelic distributions. IVS II-I and Fr 36-37 were identified as the most prevalent mutations. These results are consistent with findings from other regions in central Iran and can serve as a foundation for β-thalassemia screening and prenatal diagnosis programs. | ||
| کلیدواژه‌ها | ||
| β-thalassemia؛ ARMS-PCR؛ Kashan؛ Mutation؛ Screening | ||
| مراجع | ||
|
Abbas R. A., Hassan, R. H., Taghlubee, I. M., Mohammed, S. I., Mohammed, H. H., Hasan, H. H., Judi, A. T., Ali, L. S., Mohammed, W. J., & Shihab, H. M. (2024). Prevalence and molecular characterization of β-thalassemia in Kirkuk province of Northern Iraq. Hemoglobin, 48(5), 308- 313. https://doi.org/10.1080/03630269.2024.2418507 Afzali, H., Moosavi, G. A., & Ekinchi, H. (2000). Prevalence of Iron deficiency anemia and minor beta-thalassemia and comparison of their red cells indices in volunteers for marriage referred to Golabchi outpatient clinic in Kashan in 1376- 77. Feyz Medical Sciences Journal, 3 (4), 78- 83. http://feyz.kaums.ac.ir/article-1-484-en.html Alizadeh, S., Bavarsad, M. S., Dorgalaleh, A., Khatib, Z. K., Dargahi, H., Nassiri, N., ... & Saki, N. (2014). Frequency of beta-thalassemia or beta-hemoglobinopathy carriers simultaneously affected with alpha-thalassemia in Iran. Clinical Laboratory, 60(6), 941-9. https://doi.org/10.7754/clin.lab.2013.130306 Bajwa, H., & Basit, H. (2023). Thalassemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK545151/ Cooley, T. B., Witwer, E. R., & Lee, P. (1927). Anemia in children: with splenomegaly and peculiar changes in the bones report of cases. American Journal of Diseases of Children, 34(3), 347-363. https://doi.org/10.1001/archpedi.1925.04120210054006 Cürük, M. A., Yüregir, G. T., Asadov, C. D., Dadasova, T., Gu, L.-H. Baysal, E., Gu, Y.-C. R., S., M. L., & Huisman, T. H. (1992). Molecular characterization of β-thalassemia in Azerbaijan. Human Genetics, 90, 417-419. https://doi.org/10.1007/BF00220470 De Sanctis, V., Kattamis, C., Canatan, D., Soliman, A. T., Elsedfy, H., Karimi, M., ... & Angastiniotis, M. (2017). β-thalassemia distribution in the old world: an ancient disease seen from a historical standpoint. Mediterranean Journal of Hematology and Infectious Diseases, 9(1), e2017018. https://doi.org/10.4084/MJHID.2017.018 Hamamy, H. A., & Al-Allawi, N. A. (2013). Epidemiological profile of common haemoglobinopathies in Arab countries. Journal of Community Genetics, 4, 147-167. https://doi.org/10.1007/s12687-012-0127-8 Hammoud, H., Ghanem, R., Abdalla, R., Semaan, P., Azzi, J., Prada, E. P., & Hassan, K. H. (2020). Genetic mutations of beta thalassemia in middle east countries. World Journal of Pharmaceutical Sciences, 9, 134-150. https://doi.org/10.20959/wjpps20202-15449 Hamzehloei, T., & Mohajer, T. F. (2012). The spectrum of mutations in 100 thalassemic carriers referred to Ghaem Hospital of Mashhad. Iranian Journal of Pediatric Hematology and Oncology, 2(2), 49-53. https://ijpho.ssu.ac.ir Hashemizadeh, H., & Noori, R. (2013). Premarital screening of beta thalassemia minor in north-east of Iran. Iranian Journal of Pediatric Hematology and Oncology, 3(1), 210-215. https://ijpho.ssu.ac.ir/ Khan, A. M., Al-Sulaiti, A. M., Younes, S., Yassin, M., & Zayed, H. (2021). The spectrum of beta-thalassemia mutations in the 22 Arab countries: a systematic review. Expert Review of Hematology, 14(1), 109-122. https://doi.org/10.1080/17474086.2021.1860003 Khanahmad, H., Azadmanesh, K., Shokrgozar, M., Niavarani, A., Karimi, M., Rabbani, B., Khalili, M., … & Zeinali, S. (2007). Design & constructing pBGGT plasmid: a carrier plasmid for betathalassaemia gene targeting. Innovative Journal of Pediatrics, 16 (1), 63-70. https://brieflands.com/journals/ij-pediatrics Kiani, A., Ghorbani Aliabadi, E., Kermani, B., Rezabeigi Davarani, F., Rahmanian, V., & Daneshi, S. (2024). Assessing the success and effectiveness of the major β-thalassemia screening program in Southeast Iran: A case study of Jiroft district. Journal of Health Sciences and Surveillance System, 12(3), 319-326. https://doi.org/10.30476/jhsss.2023.97455.1707 Miller, S. A., Dykes, D. D., & Polesky, H. (1988). A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research, 16(3), 1215. https://doi.org/10.1093/nar/16.3.1215 Miri, M., Tabrizi Namini, M., Hadipour Dehshal, M., Sadeghian Varnosfaderani, F., Ahmadvand, A., Yousefi Darestani, S., & Manshadi, M. (2013). Thalassemia in Iran in last twenty years: the carrier rates and the births trend. Iranian Journal of Blood and Cancer, 6 (1), 11-17. http://ijbc.ir/ Mohammadi Asl, J., Samarafzadeh, A., Makvandi, M., Zandian, K., & Pedram, M. (2007). Investigation of common beta-globin gene mutations in patients with thalassemia major in Khuzestan Province using the RDB method. Journal of Epidemiology and Global Health, 8(3), 189-195. https://doi.org/10.5336/medsci.2008-8156 Mousavi S. S., H. Karam I, A. Tamadoni, H. Mahmoudi, R. Shekarriz, & R. Siami, e. a. (2024). Spectrum of Beta‐thalassemia mutations in potential carriers with microcytic hypochromic anemia from Mazandaran and Golestan, Northern Provinces of Iran. BioMed Research International, 2013, 8664803. https://doi.org/10.1155/2024/8664803 Nasiri, A., Rahimi, Z., & Vaisi-Raygani, A. (2020). Hemoglobinopathies in Iran: an updated review. International Journal of Hematology-Oncology and Stem Cell Research, 14(2), 140- 150. https://doi.org/10.1155/2013/803487 Nezhad, F. H., Nezhad, K. H., Choghakabodi, P. M., & Keikhaei, B. (2018). Prevalence and genetic analysis of α- and β-thalassemia and sickle cell anemia in Southwest Iran. Journal of Epidemiology and Global Health, 8(3), 189-195. https://doi.org/10.2991/j.jegh.2018.04.103 Pooladi, A., Gheshlagh, R. G., Kahrizi, N., Roshani, D., Jalali, C., & Moradveisi, B. (2022). The spectrum of alpha and beta thalassemia mutations: a 10-year population-based study of the premarital health screening program in West of Iran. Iranian Journal of Pediatric Hematology and Oncology, 12 (3), 190-198. http://ijpho.ssu.ac.ir Pouranfard, J., Vafaei, F., Afrouz, S., & Rezaeian, M. (2020). Thalassemia gene mutations in Kohgiluyeh and Boyer-Ahmad province. Iranian Journal of Blood and Cancer, 12(1), 18-23. http://ijbc.ir Rahimi, Z. (2013). Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran. BioMed Research International, 2013, 803487. https://doi.org/10.1155/2013/803487 Rao, E., Chandraker, S. K., Singh, M. M., & Kumar, R. (2024). Global distribution of β-thalassemia mutations: an update. Gene, 896, 148022. https://doi.org/10.1016/j.gene.2023.148022 Rezaee, A. R., Banoei, M. M., Khalili, E., & Houshmand, M. (2012). Beta‐thalassemia in Iran: new insight into the role of genetic admixture and migration. The Scientific World Journal, 2012(1), 635183. https://doi.org/10.1100/2012/635183 Saleh-Gohari, N., & Bazrafshani, M. (2010). Distribution of β-globin gene mutations in thalassemia minor population of Kerman Province, Iran. Iranian Journal of Public Health, 39(2), 69-76. https://ijph.tums.ac.ir/index.php/ijph Strauss, B. S. (2009). Genetic counseling for thalassemia in the Islamic Republic of Iran. Perspectives in Biology and Medicine, 52(3), 364-376. https://doi.org/10.1353/pbm.0.0093 Whipple, G. H., & Bradford, W. (1932). Racial or familial anemia of children: associated with fundamental disturbances of bone & pigment metabolism (Cooley-Von Jaksch). American Journal of Diseases of Children, 44(2), 336-365. https://doi.org/10.1001/archpedi.1932.01950090074009 | ||
|
آمار تعداد مشاهده مقاله: 11 تعداد دریافت فایل اصل مقاله: 9 |
||